Department of Pharmacy, Toulouse University Hospital, Toulouse, France.
Institute of Aging, Gérontopôle, INSPIRE Project, Toulouse University Hospital, Toulouse, France.
Drugs Aging. 2022 May;39(5):367-375. doi: 10.1007/s40266-022-00938-x. Epub 2022 May 24.
Potentially inappropriate medication prescribing (PIP) among older patients is associated with an increased risk of adverse events and hospitalization, and sometimes increased healthcare costs.
The aim of this study was to explore the association between healthcare costs and PIP exposure among older patients.
Analyses were conducted using data from the Multidomain Alzheimer Preventive Trial (MAPT). A computer algorithm was constructed to detect PIP based on various different explicit criteria-based tools, and the results were expressed in number of medication-related potential non-compliances (MRNCs). A prescription was considered potentially inappropriate if there were one or more MRNCs. We performed a cost analysis from the French National Health Insurance perspective, and also performed a multivariate analysis to identify the association between healthcare costs and PIP (number of MRNCs).
The computer algorithm analyzed medication prescribing from included patients (N = 1525 aged 75.3 ± 4.4 years; 64% women [n = 978]). PIP was associated with increased total healthcare costs and non-medication healthcare costs after adjusting for potential confounders. We also noted that healthcare costs tended to increase with the number of MRNCs. The mean additional healthcare costs were €517, €921, and €1669 per patient and year for patients with one or two MRNCs, three or four MRNCs, and five or more MRNCs, respectively, in comparison with patients with appropriate medication prescriptions.
These observations led us to conclude that interventions focused on reducing PIP could result in savings.
ClinicalTrials.gov: NCT00672685.
老年人潜在不适当药物处方(PIP)与不良事件和住院风险增加相关,有时还会增加医疗保健成本。
本研究旨在探讨老年患者中医疗保健成本与 PIP 暴露之间的关系。
使用多领域阿尔茨海默病预防试验(MAPT)的数据进行分析。构建了一个计算机算法,根据各种不同的基于明确标准的工具来检测 PIP,并以药物相关潜在不合规数量(MRNCs)表示结果。如果存在一个或多个 MRNCs,则认为处方是潜在不适当的。我们从法国国家健康保险的角度进行了成本分析,并进行了多变量分析,以确定医疗保健成本与 PIP(MRNCs 数量)之间的关系。
计算机算法分析了纳入患者(年龄 75.3±4.4 岁;64%为女性[n=978])的药物处方。在调整了潜在混杂因素后,PIP 与总医疗保健成本和非药物医疗保健成本增加相关。我们还注意到,随着 MRNC 数量的增加,医疗保健成本趋于增加。与适当药物处方的患者相比,每个患者每年的额外医疗保健费用分别为 517 欧元、921 欧元和 1669 欧元,用于具有一个或两个 MRNCs、三个或四个 MRNCs 和五个或更多 MRNCs 的患者。
这些观察结果使我们得出结论,针对减少 PIP 的干预措施可能会带来节省。
ClinicalTrials.gov:NCT00672685。